Open AccessAbstract 812: Multiplatform modeling of pancreatic cancer using patient-derived cells: A new approach for defining drug resistance mechanisms
Author(s) -
Erika Parasido,
Praathibha Sripadhan,
George S. Avetian,
Richard Schlegel,
Jonathan R. Brody,
Jordan M. Winter,
Charles J. Yeo,
Michael J. Pishvaian,
Erik Glasgow,
Stephen W. Byers,
Christopher Albanese
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-812
Subject(s) - gemcitabine , kras , paclitaxel , cancer , pancreatic cancer , cancer research , medicine , cell culture , drug resistance , zebrafish , in vivo , reprogramming , drug , bioinformatics , oncology , biology , cell , pharmacology , gene , colorectal cancer , genetics